GlassScriptPhysician profile
Oliver Dorigo
NPI 1306873294
$84,527.64
in general payments reported to CMS, 2019-2025
19 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what 76% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $8,472 · 2021: $12K · 2022: $70.01 · 2023: $8,379 · 2024: $5,025 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Education: $2,500 · Food and Beverage: $1,219 · Travel and Lodging: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,379.26 |
| Education | $2,500.00 |
| Food and Beverage | $1,218.75 |
| Travel and Lodging | $989.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $39,595.32 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15,341.28 | 2019-2024 | Lynparza |
| Immunogen, INC. | $9,204.17 | 2023-2024 | Elahere, Elahere |
| Glaxosmithkline, LLC. | $5,437.50 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $3,500.00 | 2019-2021 | |
| Intuitive Surgical, INC. | $2,565.42 | 2019-2025 | |
| Clovis Oncology, INC. | $2,100.94 | 2019 | |
| Eisai INC. | $1,875.00 | 2021 | |
| Blueprint Medicines Corporation | $1,680.00 | 2021 | |
| Genentech USA, INC. | $1,330.00 | 2019 | |
| Eli Lilly and Company | $1,053.00 | 2025 | |
| Abbvie INC. | $616.93 | 2024-2025 | |
| Medtronic, INC. | $182.67 | 2025 | Signia, Ligasure |
| Myriad Genetic Laboratories, INC. | $45.41 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Dorigo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.